Cecilia C. Low Wang

Endocrinology, Diabetes and Metabolism · 2016

A researcher in the Science corpus: 1 paper; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Cecilia C. Low Wang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. B. J. Gersh
  2. P. Ridker
  3. W. Paulus
  4. K. Bornfeldt
  5. I. Tabas
  6. C. Emdin
  7. W. Knowler
  8. C. Tschöpe
  9. Silvio E. Inzucchi
  10. Peter Libby

Papers from Cecilia C. Low Wang's perspective

Ordered by how strongly the researchers Cecilia C. Low Wang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus (New England Journal of Medicine)
  2. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. (New England Journal of Medicine)
  3. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
  4. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes (Current Atherosclerosis Reports)
  5. Effects of torcetrapib in patients at high risk for coronary events. (New England Journal of Medicine)
  6. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. (Journal of the American College of Cardiology)
  7. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. (The Lancet)
  8. Insulin Resistance, Hyperglycemia, and Atherosclerosis (Cell Metabolism)
  9. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. (New England Journal of Medicine)
  10. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. (The Lancet)

Their papers